Most recent
-
22 Oct 2014:
Nils Pratley: Despite the HIV unit’s nailed-on FTSE 100 status, it is only a small part of GSK, which is worth almost £80bn
-
22 Oct 2014: Pharmaceuticals group says ViiV Healthcare could be worth more than Marks & Spencer or Sainsbury’s if allowed to stand alone
-
22 Oct 2014:
Barclays analysts say healthcare group’s shares benefit whether it is predator or prey
-
25 Sep 2014: Rolling business and financial news, as Bank of England governor warns that “an abrupt correction in term and risk premia” could hit securities valuations hard
-
25 Sep 2014: Sir Phillip Hampton took reins of troubled bank at height of credit crisis and will move to pharmaceuticals firm by September 2015
-
24 Sep 2014:
Sir Philip Hampton to exchange similar roles from bailed out bank to embattled pharmaceutical company at the end of 2015
-
22 Sep 2014: Markets under pressukre as investors desert supermarket group and mining shares
-
19 Sep 2014: It's good news that Mark Reilly is not going to prison – but what of GSK chief executive Sir Andrew Witty's ethical agenda?
-
19 Sep 2014:
Mark Reilly given three-year suspended prison sentence after pleading guilty to bribery during one-day trial in Hunan Province
-
19 Sep 2014: Mark Reilly and executives face up to four years in jail over claims that sales team bribed doctors to prescribe company medicine
-
17 Sep 2014: Safety trials of experimental drug at University of Oxford offers hope in west Africa, where virus has killed 53% of those infected
-
16 Sep 2014:
Some of the largest multinational companies to be forced to contribute towards government budgets
-
Guardian Professional, 8 Sep 2014: If sustainability is about benefitting people in the long-term, community engagement must play a central role
-
28 Aug 2014:
Clinical safety trials begin in US next week, after approval from the FDA; volunteer testing in UK and Africa from September
-
27 Aug 2014: Water company United Utilities among fallers after broker downgrade
1-15 of 725 for GlaxoSmithKline
